NVCR
NVCR
NASDAQ · Health Care

Novocure Ltd

$11.68
+0.32 (+2.82%)
As of Mar 25, 2:05 PM ET ·
Financial Highlights (FY 2026)
Revenue
636.32M
Net Income
-177,296,652
Gross Margin
77.3%
Profit Margin
-27.9%
Rev Growth
+4.2%
D/E Ratio
1.82
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 77.3% 77.3% 51.4% 51.4%
Operating Margin -28.2% -25.4% 23.4% 21.7%
Profit Margin -27.9% -26.5% 17.5% 18.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 636.32M 610.67M 251.06M 253.67M
Gross Profit 492.13M 472.29M 129.14M 130.49M
Operating Income -179,251,387 -154,823,654 58.84M 55.04M
Net Income -177,296,652 -153,135,304 43.96M 45.64M
Gross Margin 77.3% 77.3% 51.4% 51.4%
Operating Margin -28.2% -25.4% 23.4% 21.7%
Profit Margin -27.9% -26.5% 17.5% 18.0%
Rev Growth +4.2% +4.2% -1.9% +7.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 411.57M 411.57M 319.88M 342.35M
Total Equity 226.16M 226.16M 378.69M 362.47M
D/E Ratio 1.82 1.82 0.84 0.94
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -138,352,157 -126,136,803 70.91M 75.95M
Free Cash Flow 20.52M 25.20M